Diagnosing progressive supranuclear palsy: Role of biological and neuroimaging markers
Open accessAbstract
Progressive Supranuclear Palsy (PSP) is a neurodegenerative disorders characterised by a kinetic-rigid syndrome with ocular motor dysfunction, postural instability, and frontal lobe and bulbar dysfunction. In most of the cases, especially at early disease stages, diagnosis is still challenging. PSP signs and symptoms may indeed overlap with both dementing neurodegenerative syndromes and movement disorders. In the last few years, a better definition of clinical picture along with the identification of biological and neuroimaging markers have increased diagnostic accuracy. In the present work, we reviewed the current literature on PSP diagnosis and the usefulness of potential diagnostic markers.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Subjects with PSP showed structural alterations in connections encompassing the thalamus.
“while the subjects with PSP showed structural alterations in connections encompassing the thalamus (Borroni et al., 2014; Whitwell et al., 2011a).”
From Multiclass characterization of frontotemporal dementia variants via multimodal brain network computational inference (2023) · cites this paper as Borroni et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · see citing works
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · see citing works
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538 · see citing works
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492 · see citing works
Progressive Supranuclear Palsy
Steele, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,930 · see citing works
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869 · see citing works
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474 · see citing works
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
Litvan, I., Bhatia, K. P., Burn, D. J., Goetz, C. G., Lang, A. E., McKeith, I. G., Quinn, N. P., Sethi, K. D., Shults, C. W., & Wenning, G. K. (2003) · Movement Disorders · doi:10.1002/mds.10459 · Cited by 1,006 · see citing works
Hauw, J., Daniel, S. E., Dickson, D. W., Horoupian, D. S., Jellinger, K. A., Lantos, P. L., McKee, A. C., Tabaton, M., & Litvan, I. (1994) · Neurology · doi:10.1212/wnl.44.11.2015 · Cited by 854 · see citing works
Association of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy
Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781 · see citing works
Williams, D. R., de Silva, R., Paviour, D. C., Pittman, A. M., Watt, H., Kilford, L., Holton, J. L., Révész, T., & Lees, A. J. (2005) · Brain · doi:10.1093/brain/awh488 · Cited by 733 · see citing works
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy
Borroni, B., Malinverno, M., Gardoni, F., Alberici, A., Parnetti, L., Premi, E., Bonuccelli, U., Grassi, M., Perani, D., Calabresi, P., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000335941.68602.39 · Cited by 677 · see citing works
Mollenhauer, B., Locascio, J. J., Schulz‐Schaeffer, W., Sixel‐Döring, F., Trenkwalder, C., & Schlossmacher, M. G. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70014-x · Cited by 623 · see citing works
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
PSP Genetics Study Group, Höglinger, G. U., Melhem, N. M., Dickson, D. W., Sleiman, P. M. A., Wang, L.-S., Klei, L., Rademakers, R., de Silva, R., Litvan, I., et al. (2011) · Nature Genetics · doi:10.1038/ng.859 · Cited by 603 · see citing works
Boeve, B. F., Lang, A. E., & Litvan, I. (2003) · Annals of Neurology · doi:10.1002/ana.10570 · Cited by 526 · see citing works
Hall, S., Öhrfelt, A., Constantinescu, R., Andreasson, U., Surova, Y., Bostrom, F., Nilsson, C., Widner, H., Decraemer, H., Nägga, K., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1654 · Cited by 473 · see citing works
Quattrone, A., Nicoletti, G., Messina, D., Fera, F. S., Condino, F., Pugliese, P., Lanza, P. L., Barone, P., Morgante, L., Zappia, M., et al. (2007) · Radiology · doi:10.1148/radiol.2453061703 · Cited by 418 · see citing works
Williams, D. R., Holton, J. L., Strand, C., Pittman, A. M., de Silva, R., Lees, A. J., & Révész, T. (2007) · Brain · doi:10.1093/brain/awm104 · Cited by 415 · see citing works
New and reliable MRI diagnosis for progressive supranuclear palsy
Oba, H., YAGISHITA, A., Terada, H., Barkovich, A. J., Kutomi, K., Yamauchi, T., Furui, S., Shimizu, T., Uchigata, M., Matsumura, K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000165960.04422.d0 · Cited by 374 · see citing works
Litvan, I., Agid, Y., Jankovic, J. J., Goetz, C. G., Brandel, J., Lai, E. C., Wenning, G. K., D'Olhaberriague, L., Verny, M., Chaudhuri, К. R., et al. (1996) · Neurology · doi:10.1212/wnl.46.4.922 · Cited by 347 · see citing works
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study
Bensimon, G., Ludolph, A., Agid, Y., Vidailhet, M., Payan, C., & Leigh, P. N. (2008) · Brain · doi:10.1093/brain/awn291 · Cited by 345 · see citing works
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
Schoonenboom, N. S. M., Reesink, F. E., Verwey, N. A., Kester, M. I., Teunissen, C. E., van de Ven, P. M., Pijnenburg, Y. A. L., Blankenstein, M. A., Rozemuller, A. J., Scheltens, P., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31823ed0f0 · Cited by 302 · see citing works
Pittman, A. M., Myers, A. J., Abou‐Sleiman, P. M., Fung, H., Kaleem, M., Marlowe, L., Duckworth, J., Leung, D. G., Williams, D. R., Kilford, L., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.031377 · Cited by 275 · see citing works
Stanford, P. M., Halliday, G. M., Brooks, W. S., Kwok, J. B. J., Storey, C. E., Creasey, H., Morris, J. G. L., Fulham, M. J., & Schofield, P. R. (2000) · Brain · doi:10.1093/brain/123.5.880 · Cited by 262 · see citing works
Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias
López, O. L., Litvan, I., Catt, K. E., Stowe, R., Klunk, W. E., Kaufer, D., Becker, J. T., & DeKosky, S. T. (1999) · Neurology · doi:10.1212/wnl.53.6.1292 · Cited by 238 · see citing works
Imaging Approaches to Parkinson Disease
Brooks, D. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.059998 · Cited by 234 · see citing works
Specific Pathological Tau Protein Variants Characterize Pickʼs Disease
Delacourte, A., Robitaille, Y., Sergeant, N., Buée, L., Hof, P. R., Wattez, A., Laroche-Cholette, A., Mathieu, J., Chagnon, P., & Gauvreau, D. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199602000-00004 · Cited by 224 · see citing works
Massey, L. A., Micallef, C., Paviour, D. C., O’Sullivan, S. S., Ling, H., Williams, D. R., Kallis, C., Holton, J. L., Révész, T., Burn, D. J., et al. (2012) · Movement Disorders · doi:10.1002/mds.24968 · Cited by 211 · see citing works
Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease
Meredith Jr., J. E., Sankaranarayanan, S., Guss, V., Lanzetti, A. J., Berisha, F., Neely, R. J., Slemmon, J. R., Portelius, E., Zetterberg, H., Blennow, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076523 · Cited by 209 · see citing works
Cerebrospinal fluid biomarkers in Parkinson disease
Parnetti, L., Castrioto, A., Chiasserini, D., Persichetti, E., Tambasco, N., El-Agnaf, O., & Calabresi, P. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.10 · Cited by 209 · see citing works
Measurement of the Midbrain Diameter on Routine Magnetic Resonance Imaging
Warmuth‐Metz, M., Naumann, M. K., Csóti, I., & Solymosi, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.7.1076 · Cited by 202 · see citing works
An R5L τ mutation in a subject with a progressive supranuclear palsy phenotype
Poorkaj, P., Muma, N. A., Zhukareva, V. A., Cochran, E. J., Shannon, K. M., Hurtig, H. I., Koller, W. C., Bird, T. D., Trojanowski, J. Q., Lee, V. M. ‐., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10340 · Cited by 196 · see citing works
Hereditary Frontotemporal Dementia Caused by <i>Tau</i> Gene Mutations
Van Swieten, J., & Spillantini, M. G. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00052.x · Cited by 195 · see citing works
Abnormal metabolic networks in atypical parkinsonism
Eckert, T., Tang, C., Ma, Y., Brown, N., Lin, T. P., Frucht, S. J., Feigin, A., & Eidelberg, D. (2008) · Movement Disorders · doi:10.1002/mds.21933 · Cited by 191 · see citing works
Accuracy of clinical diagnosis of progressive supranuclear palsy
Osaki, Y., Ben‐Shlomo, Y., Lees, A. J., Daniel, S. E., Colosimo, C., Wenning, G. K., & Quinn, N. P. (2003) · Movement Disorders · doi:10.1002/mds.10680 · Cited by 184 · see citing works
Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy
Padovani, A. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.075713 · Cited by 177 · see citing works
Disrupted thalamocortical connectivity in PSP: A resting-state fMRI, DTI, and VBM study
Whitwell, J. L., Avula, R. T. V., Master, A. V., Vemuri, P., Senjem, M. L., Jones, D. T., Jack, C. R., & Josephs, K. A. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.05.013 · Cited by 174 · see citing works
Delisle, M., Murrell, J. R., Richardson, R., Trofatter, J. A., Rascol, O., Soulages, X., Mohr, M., Calvas, P., & Ghetti, B. F. (1999) · Acta Neuropathologica · doi:10.1007/s004010051052 · Cited by 171 · see citing works
Rademakers, R., Melquist, S., Cruts, M., Theuns, J., Del-Favero, J., Poorkaj, P., Baker, M., Sleegers, K., Crook, R., De Pooter, T., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi361 · Cited by 164 · see citing works
Study of the rostral midbrain atrophy in progressive supranuclear palsy
加藤, 直. (2003) · Medical Entomology and Zoology · Cited by 150 · see citing works
Respondek, G., Roeber, S., Kretzschmar, H. A., Troakes, C., Al‐Sarraj, S., Gelpí, E., Gaig, C., Chiu, W. Z., Swieten, J. C. V., Oertel, W. H., et al. (2013) · Movement Disorders · doi:10.1002/mds.25327 · Cited by 149 · see citing works
Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease
Eidelberg, D., Takikawa, S., Moeller, J. R., DHAWAN, V. M., Redington, K., Chaly, T., Robeson, W., Dahl, J., Margouleff, D., Fazzini, E. P., et al. (1993) · Annals of Neurology · doi:10.1002/ana.410330517 · Cited by 139 · see citing works
Haplotype-specific expression of exon 10 at the human MAPT locus
Caffrey, T. M., Joachim, C. L., Paracchini, S., Esiri, M. M., & Wade‐Martins, R. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl429 · Cited by 135 · see citing works
Wagshal, D., Sankaranarayanan, S., Guss, V., Hall, T., Berisha, F., Lobach, I., Karydas, A., Voltarelli, L., Scherling, C., Heuer, H., et al. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308004 · Cited by 132 · see citing works
Williams, D. R., & Lees, A. J. (2010) · Movement Disorders · doi:10.1002/mds.22977 · Cited by 129 · see citing works
Morning Glory Sign: A Particular MR Finding in Progressive Supranuclear Palsy
Adachi, M., Kawanami, T., OHSHIMA, H., Sugai, Y., & Hosoya, T. (2004) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.3.125 · Cited by 117 · see citing works
Intrinsic connectivity network disruption in progressive supranuclear palsy
Gardner, R. C., Boxer, A. L., Trujillo, A. J., Mirsky, J. B., Guo, C. C., Gennatas, E. D., Heuer, H. W., Fine, E. M., Zhou, J. H., Kramer, J. H., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23844 · Cited by 106 · see citing works
The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family
Spina, S., Farlow, M. R., Unverzagt, F. W., Kareken, D. A., Murrell, J. R., Fraser, G. M., Epperson, F., Crowther, R. A., Spillantini, M. G., Goedert, M., et al. (2007) · Brain · doi:10.1093/brain/awm280 · Cited by 102 · see citing works
Constantinescu, R., Rosengren, L., Johnels, B., Zetterberg, H., & Holmberg, B. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.07.007 · Cited by 101 · see citing works
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy
Borroni, B., Gardoni, F., Parnetti, L., Magno, L., Malinverno, M., Saggese, E., Calabresi, P., Spillantini, M. G., Padovani, A., & Luca, M. D. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.009 · Cited by 100 · see citing works
Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS
Ogaki, K., Li, Y., Takanashi, M., Ishikawa, K., Kobayashi, T., Nonaka, T., Hasegawa, M., Kishi, M., Yoshino, H., Funayama, M., et al. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.06.019 · Cited by 93 · see citing works
Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
Magdalinou, N. K., Lees, A. J., & Zetterberg, H. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307539 · Cited by 93 · see citing works
A New Mutation of the τ Gene, G303V, in Early-Onset Familial Progressive Supranuclear Palsy
Ros, R., Thobois, S., Streichenberger, N., Kopp, N., Sánchez, M. P., Pérez, M., Hoenicka, J., Ávila, J., Honnorat, J., & de Yébenes, J. G. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.1444 · Cited by 92 · see citing works
Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP
Morris, H. R., Osaki, Y., Holton, J. L., Lees, A. J., Wood, N. W., Révész, T., & Quinn, N. P. (2003) · Neurology · doi:10.1212/01.wnl.0000072325.27824.a5 · Cited by 92 · see citing works
Rational therapeutic approaches to progressive supranuclear palsy
Stamelou, M., de Silva, R., Arias-Carrion, O., Boura, E., Hollerhage, M., Oertel, W. H., Muller, U., & Hoglinger, G. U. (2010) · Brain · doi:10.1093/brain/awq115 · Cited by 91 · see citing works
Hu, W. T., Chen‐Plotkin, A. S., Arnold, S. E., Grossman, M., Clark, C. M., Shaw, L. M. J., McCluskey, L. F., Elman, L. B., Karlawish, J. H., Hurtig, H. I., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0723-9 · Cited by 90 · see citing works
Südmeyer, M., Antke, C., Zizek, T., Beu, M., Nikolaus, S., Wojtecki, L., Schnitzler, A., & Müller, H. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.086959 · Cited by 88 · see citing works
Penguins and hummingbirds: Midbrain atrophy in progressive supranuclear palsy
Gröschel, K., Kastrup, A., Litvan, I., & Schulz, J. B. (2006) · Neurology · doi:10.1212/01.wnl.0000203342.77115.bf · Cited by 85 · see citing works
Aiba, I., Hashizume, Y., Yoshida, M., Okuda, S., Murakami, N., & Ujihira, N. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00166-4 · Cited by 83 · see citing works
MRI measurements predict PSP in unclassifiable parkinsonisms
Morelli, M., Arabia, G., Novellino, F., Salsone, M., Giofrè, L., Condino, F., Messina, D. N., & Quattrone, A. (2011) · Neurology · doi:10.1212/wnl.0b013e31822e55d0 · Cited by 82 · see citing works
Familial aggregation of parkinsonism in progressive supranuclear palsy
Kaat, L. D., Boon, A. J. W., Azmani, A., Kamphorst, W., Breteler, M. M. B., Anar, B., Heutink, P., & Swieten, J. C. V. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a92bcc · Cited by 81 · see citing works
Follow-up study of risk factors in progressive supranuclear palsy
Golbe, L. I., Rubin, R. S., Cody, R. P., Belsh, J. M., Duvoisin, R. C., Grosmann, C., Lepore, F. E., Mark, M. H., Sachdeo, R. C., Sage, J. I., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.148 · Cited by 79 · see citing works
Knake, S., Belke, M., Menzler, K., Pilatus, U., Eggert, K. M., Oertel, W. H., Stamelou, M., & Höglinger, G. U. (2010) · Movement Disorders · doi:10.1002/mds.23054 · Cited by 76 · see citing works
Noguchi, M., Yoshita, M., Matsumoto, Y., Ono, K., Iwasa, K., & Yamada, M. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.05.015 · Cited by 72 · see citing works
123I‐IBZM binding compared with long‐term clinical follow up in patients with de novo parkinsonism
Schwarz, J., Tatsch, K., Gasser, T., Arnold, G., Pogarell, O. M., Künig, G., & Oertel, W. H. (1998) · Movement Disorders · doi:10.1002/mds.870130107 · Cited by 72 · see citing works
FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants
Zalewski, N. L., Botha, H., Whitwell, J. L., Lowe, V. J., Dickson, D. W., & Josephs, K. A. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7256-4 · Cited by 71 · see citing works
Biological fluid biomarkers in neurodegenerative parkinsonism
Eller, M., & Williams, D. R. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.135 · Cited by 71 · see citing works
Melquist, S., Craig, D. W., Huentelman, M. J., Crook, R., Pearson, J. V., Baker, M. C., Zismann, V., Gass, J. M., Adamson, J. L., Szelinger, S., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/513320 · Cited by 70 · see citing works
Cherubini, A., Morelli, M., Nisticò, R., Salsone, M., Arabia, G., Vasta, R., Augimeri, A., Caligiuri, M. E., & Quattrone, A. (2013) · Movement Disorders · doi:10.1002/mds.25737 · Cited by 70 · see citing works
Sajjadi, S., Acosta-Cabronero, J., Patterson, K., Diaz-de-Grenu, L. Z., Williams, G. B., & Nestor, P. (2013) · Brain : a journal of neurology · doi:10.1093/brain/awt118 · Cited by 63 · see citing works
Luk, C. Y., Compta, Y., Magdalinou, N. K., Martı́, M. J., Hondhamuni, G., Zetterberg, H., Blennow, K., Constantinescu, R., Pijnenburg, Y. A. L., Mollenhauer, B., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07911.x · Cited by 62 · see citing works
Agosta, F., Galantucci, S., Svetel, M., Lukić, M., Copetti, M., Davidovic, K., Tomić, A., Spinelli, E., Kostic, V., & Filippi, M. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7301-3 · Cited by 60 · see citing works
Cognitive, neuroimaging, and pathological studies in a patient with Pick's disease
Lieberman, A. P., Trojanowski, J. Q., Lee, V. M. ‐., Balin, B. J., Ding, X., Greenberg, J., Morrison, D., Reivich, M., & Grossman, M. (1998) · Annals of Neurology · doi:10.1002/ana.410430218 · Cited by 54 · see citing works
Rohrer, J. D., Paviour, D. C., Vandrovcová, J., Hodges, J. R., de Silva, R., & Rossor, M. N. (2010) · Neurodegenerative Diseases · doi:10.1159/000319454 · Cited by 54 · see citing works
An extended 5′- <i>tau</i> susceptibility haplotype in progressive supranuclear palsy
Higgins, J. J., Golbe, L. I., Biase, A. D., Jankovic, J., Factor, S. A., & Adler, R. L. (2000) · Neurology · doi:10.1212/wnl.55.9.1364 · Cited by 49 · see citing works
Risk factors for progressive supranuclear palsy: a case-control study in France
Vidal, J., Vidailhet, M., Derkinderen, P., Gaillarbois, T. D. D., Tzourio, C., & Alpérovitch, A. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.149849 · Cited by 49 · see citing works
Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes
Bech, S., Hjermind, L. E., Salvesen, L., Nielsen, J. E., Heegaard, N. H. H., Jørgensen, H. L., Rosengren, L., Blennow, K., Zetterberg, H., & Winge, K. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.08.012 · Cited by 47 · see citing works
Differential pattern of brain‐specific CSF proteins tau and amyloid‐beta in Parkinsonian syndromes
Süßmuth, S. D., Uttner, I., Landwehrmeyer, G. B., Pinkhardt, E. H., Brettschneider, J., Petzold, A., Kramer, B., Schulz, J. B., Palm, C., Otto, M., et al. (2010) · Movement Disorders · doi:10.1002/mds.22895 · Cited by 47 · see citing works
Differentiation of Progressive Supranuclear Palsy: clinical, imaging and laboratory tools
Liščić, R. M., Srulijes, K., Gröger, A., Maetzler, W., & Berg, D. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12067 · Cited by 40 · see citing works
Srulijes, K., Reimold, M., Liščić, R. M., Bauer, S., Dietzel, E., Liepelt‐Scarfone, I., Berg, D., & Maetzler, W. (2011) · Movement Disorders · doi:10.1002/mds.23975 · Cited by 37 · see citing works
Tsuboi, Y., Uitti, R. J., Delisle, M., Ferreira, J. J., Brefel‐Courbon, C., Rascol, O., Ghetti, B. F., Murrell, J. R., Hutton, M. L., Baker, M., et al. (2002) · PubMed · doi:10.1001/archneur.59.6.943 · Cited by 37 · see citing works
Saini, J. S., Bagepally, B. S., Mangalore, S., Pasha, S. A., Yadav, R., & Pal, P. K. (2011) · Neuroradiology · doi:10.1007/s00234-011-0983-7 · Cited by 36 · see citing works
Rossi, G., Gasparoli, E., Pasquali, C., Fede, G. D., Testa, D., Albanese, A., Bracco, F., & Tagliavini, F. (2004) · Annals of Neurology · doi:10.1002/ana.20006 · Cited by 35 · see citing works
Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy
de Silva, R., Hope, A., Pittman, A. M., Weale, M. E., Morris, H. R., Wood, N. W., & Lees, A. J. (2003) · Neurology · doi:10.1212/01.wnl.0000073140.25533.90 · Cited by 26 · see citing works
Pástor, P., Muñoz, E., Ezquerra, M., Obach, V., Martı́, M. J., Valldeoriola, F., Tolosa, E. S., & Oliva, R. (2001) · Movement Disorders · doi:10.1002/mds.1198 · Cited by 25 · see citing works
Genetic Bases of Progressive Supranuclear Palsy: The MAPT Tau Disease
Borroni, B., Agosti, C., Magnani, E., Luca, M. D., & Padovani, A. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795933722 · Cited by 21 · see citing works
Borroni, B., Malinverno, M., Gardoni, F., Grassi, M., Parnetti, L., Agosti, C., Alberici, A., Premi, E., Bonuccelli, U., Gasparotti, R., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100333 · Cited by 20 · see citing works
Borroni, B., Bo, R. D., Goldwurm, S., Archetti, S., Bonvicini, C., Agosti, C., Bigni, B., Papetti, A., Ghezzi, S., Sacilotto, G., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091615 · Cited by 16 · see citing works
G303V tau mutation presenting with progressive supranuclear palsy–like features
Choumert, A., Poisson, A., Honnorat, J., Ber, I. L., Camuzat, A., Broussolle, E., & Thobois, S. (2011) · Movement Disorders · doi:10.1002/mds.24060 · Cited by 15 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Gonzalez-Gomez, R., Ibañez, A., & Moguilner, S. (2023) · Network Neuroscience · doi:10.1162/netn_a_00285 · Cited by 10 · see citing works
Kaprelyan, A. G., Tzoukeva, A. J., Bochev, P., Chaushev, B. G., & Грудкова, М. (2014) · Scripta Scientifica Medica · doi:10.14748/ssm.v46i4.1013
Tau Protein and its Phosphorylation: Alzheimer?s Disease
Singh, S. K., Dhama, N., Khan, A., & Singh, G. (2015) · Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences
Stem Cell Research Therapy for Neurodegenerative Disorders- In What Way to Make it Work
Dhama, N., Pal, P., Singh, S. K., & Nayak, S. S. (2015) · Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences
Alzheimer?s Disease and Diabetes
Reddy, D. R. K. (2015) · Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences
Azul de Metileno na Paralisia Supranuclear Progressiva, uma possibilidade?
Vilaça, C. D. O., Pessôa, B. L., Orsini, M. A., Reis, C. H. M., Azizi, M. A. A., Moreno, A. M., Bastos, V. H., & Leite, M. A. A. (2020) · Revista Neurociências · doi:10.34024/rnc.2020.v28.10210
- Authors
- Benussi A, B. B.
- Venue
- Journal of Alzheimer's Disease & Parkinsonism
- Publisher
- OMICS Publishing Group
- Published
- 2014
- Volume
- 04
- Issue
- 06
- ISSN
- 2161-0460 (ISSN-L)
- OpenAlex
- W2334139369
- Cited by
- 6
- References
- 89
- Citations by year
- 2022: 1 · 2020: 1 · 2015: 3 · 2014: 1
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Alzheimer’s Disease & Parkinsonism (publishedVersion, cc-by)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Funders
- Ministero della Salute
- National Institute of Neurological Disorders and Stroke
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- progressive supranuclear palsy, diagnosis, biomarkers, neuroimaging biomarkers, neurodegenerative diseases, eye movement disorders, postural instability, differential diagnosis, early-stage disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
